Patent ID: 8821869
Filing Date: 2014-09-02
Classification: A61K,A61P,C07K

Abstract:
1. A method for treating a hyperproliferative disorder in which c-Met is expressed in a subject in need thereof, comprising the step of administering to said subject an antibody or antigen-binding portion thereof, wherein the antibody or antigen-binding portion thereof cross-competes for binding to human c-MET and binds the same epitope as an antibody selected from the group consisting of 13.3.2 (ATCC accession PTA-5026); 9.1.2 (ATCC accession PTA-5027); 8.70.2 (ATCC accession PTA-5028); and 8.90.3 (ATCC accession PTA-5029).